BioSniper
ZH
Toggle language
Open menu
Earnings Report
positive
Earnings Report
May 6, 2026
Company
Taysha Gene Therapies, Inc. (TSHA)
Other upcoming events for TSHA
Phase 3 Readout
Phase 3 Topline: An Open-label Phase 1/2/3 Study Consisting of a Phase 1/2 Safety and Dose-escalation and Phase 3 Dos
Jun 1, 2031
Phase 3 Readout
Phase 3 Topline: ASPIRE Study: A Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary
Jun 1, 2031
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
TSHA Overview
PDUFA Dates
Phase 3 Readouts